Recent Developments of Protein Kinase Inhibitors as Potential AD Therapeutics
Present AD therapies suffer from inefficient effects on AD symptoms like memory or cognition, especially in later states of the disease. Used acteylcholine esterase (ACE) inhibitors or the NMDA receptor antagonist memantine address one target structure which is involved in a complex, multifactorial...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-11-01
|
Series: | Frontiers in Cellular Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fncel.2013.00189/full |